XBiotech Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +0.0% | -100.0% | – | – | – | -100.0% | – | – | – | – | – | |
| – | +0.5% | +0.0% | +0.2% | +0.9% | – | – | -0.7% | -2.7% | -11.5% | -12.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.4% | +25.9% | +32.2% | -45.1% | +9.7% | +48.6% | -54.1% | -4.8% | +399.2% | -79.5% | +1.7% | – | |
| – | -19.5% | +31.3% | +92.8% | -60.8% | +19.3% | +108.3% | -48.2% | -3.3% | +354.7% | -75.7% | -20.4% | – | |
| – | -4.3% | +33.1% | +37.9% | -47.2% | +10.7% | +54.9% | -53.2% | -4.6% | +392.1% | -80.0% | +3.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | -93.9% | +1.5% | +0.5% | -56.9% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -132.1% | – | -200.0% | – | -555.6% | – | -3.4% | +264.3% | -25.5% | -35.5% | -6.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.